Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Upgraded by StockNews.com
Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Saturday. A number of other research firms have also weighed in on AKBA. Leerink Partners began coverage on Akebia Therapeutics in a report on Monday, April 28th. They […]
Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Saturday. A number of other research firms have also weighed in on AKBA. Leerink Partners began coverage on Akebia Therapeutics in a report on Monday, April 28th. They […]
